US Edition
What Trump's Executive Order On Ibogaine Means For Veterans ...
The order directs federal agencies to expand trials and fast-track review vouchers as states seek $50 million for psychedelic programs.
- On Saturday, April 18, 2026, President Donald Trump signed an executive order directing federal agencies to accelerate research and clinical trials for psychedelic treatments, including psilocybin, MDMA, and ibogaine for serious mental health conditions.
- Support from conservative podcaster Joe Rogan and former Navy SEAL Marcus Luttrell prompted the order, shifting ibogaine from 'fringe and underground' to 'federally acknowledged' as advocates push for treating PTSD and addiction.
- The White House will direct $50 million in existing Department of Health and Human Services funds to support state programs, while Frederick Barrett, PhD, director of the Johns Hopkins Center for Psychedelic and Consciousness Research, cites ibogaine's 'cardiovascular toxicity' as a significant safety barrier.
- Despite the acceleration, psychedelics remain under their Schedule I status, and the Food and Drug Administration maintains that full clinical trials are required to demonstrate safety and effectiveness before approval.
- The FDA will issue national priority vouchers next week for three psychedelics, which Commissioner Marty Makary, MD, MPH, said will allow faster development 'if they are in line with our national priorities,' while expanding 'Right to Try' access.
12 Articles
12 Articles
'Terrifying!' Trump's latest 'humiliation' for the presidency leaves analyst aghast
President Donald Trump's brag that he can sign his name on an executive order better than other presidents left one analyst aghast on Monday. On Saturday, Trump signed an executive order legalizing some natural medicines to treat veterans with serious mental health challenges. Trump bragged to the a...
Trump Fast-Tracks Mental Health Treatments
President Trump signed an executive order on Saturday permitting expedited reviews of psychedelic drugs for medical use. The order, “Accelerating Medical Treatments For Serious Mental Illnesses,” seeks to address mental health crises. “Despite massive Federal investment into researching potential advancements in mental health care and treatment, our medical research system has yet to produce approved therapies that promote enduring improvements …
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
